Better Dividend Stock: AbbVie vs. Johnson & Johnson
Both companies have a lot to offer income-seekers....…
166,830€
-0,46%
Echtzeit-Aktienkurs Abbvie Inc.
Bid:
Ask:
Nachrichten zur Abbvie Inc. Aktie
AbbVie to Host First-Quarter 2023 Earnings Conference Call
NORTH CHICAGO, Ill., April 4, 2023 /PRNewswire/ -- AbbVie (NYSE: ABBV) will announce its first-quarter 2023 financial results on Thursday,…
AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know
AbbVie (ABBV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what…
Better Growth Stock: Vertex Pharmaceuticals vs. AbbVie
These stocks look reasonably priced considering their future prospects....…
Better Growth Stock: AbbVie vs. Pfizer
One of the pair will have trouble challenging its recent heights....…
Form 8-K AbbVie Inc. For: Mar 28
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
AbbVie (ABBV) Stock Sinks As Market Gains: What You Should Know
In the latest trading session, AbbVie (ABBV) closed at $157.54, marking a -0.3% move from the previous day....…
The Zacks Analyst Blog Highlights Sanofi, Regeneron, AbbVie, Roche and Eli Lilly
Sanofi, Regeneron, AbbVie, Roche and Eli Lilly are included in this Analyst Blog....…
Better Buy: AbbVie vs. Johnson & Johnson
These pharma giants beat the bear market last year....…
AbbVie (ABBV) Provides Clinical Updates on Inflammatory Drugs
AbbVie???s (ABBV) two studies evaluating Skyrizi in ulcerative colitis and Rinvoq in systemic lupus erythematosus meet their primary endpoints....…
3 Things About AbbVie That Smart Investors Know
Thinking long-term could pay off now for AbbVie investors....…
AbbVie moves Rinvoq into phase 3 for lupus
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
AbbVie: Phase 3 Induction Study With Risankizumab Meets Endpoints
BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - AbbVie (ABBV) reported positive top-line results from INSPIRE, a Phase 3 induction study, showing risankizumab met the…
2 Reasons to Buy AbbVie, and 1 Reason to Sell
AbbVie shares rose in the double digits last year....…
AbbVie: FDA Requests Additional Information Related To NDA Review Of ABBV-951
WASHINGTON (dpa-AFX) - AbbVie (ABBV) announced it received a Complete Response Letter from the FDA for the New Drug Application…
FDA Rejects AbbVie Parkinsons Treatment; Seeks More Data >ABBV
FDA Rejects AbbVie Parkinson's Treatment; Seeks More Data >ABBV...…
Should You Buy The Botox Maker Over Johnson & Johnson Stock?
Even if we look at a longer time frame, AbbVie fares better, with its sales rising at an average annual…
Value & starke Dividende: Mit dieser Aktie langfristig doppelt profitieren
Die aktuelle Unsicherheit rund um den Patentverlust seines Top-Sellers Humira bietet Value-Investoren die Chance, die Dividendenwachstumsaktie AbbVie günstig zu erwerben.
Der…
AbbVie, Gilead, Seagen among firms fined for raising prices faster than inflation
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
The Zacks Analyst Blog Highlights AbbVie, NextEra Energy, ConocoPhillips, Canadian Pacific Railway and Intercontinental Exchange
AbbVie, NextEra Energy, ConocoPhillips, Canadian Pacific Railway and Intercontinental Exchange are part of the Zacks top Analyst Blog....…
Top Research Reports for AbbVie, NextEra Energy & ConocoPhillips
Todays Research Daily features new research reports on 16 major stocks, including AbbVie Inc. (ABBV), NextEra Energy, Inc. (NEE) and…
Bristol Myers, Pfizer, AbbVie drugs likely to face U.S. price negotiation
.../WASHINGTON (Reuters) - The blood thinner Eliquis from Bristol Myers... and academic analyses shared with Reuters.
…
Pfizer, AbbVie, BMS among firms at risk of U.S. drug price negotiations - report
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Zacks Investment Ideas feature highlights: Coca-Cola Company, AbbVie and Exxon Mobil
Coca-Cola Company, AbbVie and Exxon Mobil have been highlighted in this Investment Ideas article....…
Is It Too Late to Buy AbbVie Stock?
AbbVie stock and earnings have increased over time....…
Viatris joins AbbVie and Lilly in protesting against U.K. drug pricing deal
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Insiderhandel: EVP, GC AND SECRETARY verkauft Aktien von AbbVie im Wert von 1.857.641$
Siatis, Perry C. - Vorstand - Tag der Transaktion: 2023-03-01...…
Insiderhandel: EVP, CHIEF FINANCIAL OFFICER verkauft Aktien von AbbVie im Wert von 2.440.355$
Reents, Scott T. - Vorstand - Tag der Transaktion: 2023-03-01...…
Insiderhandel: SVP, US COMMERCIAL OPERATIONS verkauft Aktien von AbbVie im Wert von 2.325.465$
Sorg, Elaine K. - Vorstand - Tag der Transaktion: 2023-03-01...…
Insiderhandel: EVP, OPERATIONS verkauft Aktien von AbbVie im Wert von 5.714.215$
Saleki-Gerhardt, Azita - Vorstand - Tag der Transaktion: 2023-03-01...…
Insiderhandel: EVP, CHIEF HR OFFICER verkauft Aktien von AbbVie im Wert von 6.766.104$
Richmond, Timothy J. - Vorstand - Tag der Transaktion: 2023-03-01...…
Thursday’s Top Analyst Upgrades and Downgrades: AbbVie, Boeing, Coupang, First Solar, Goldman Sachs, Johnson & Johnson, Monster Beverage, Rivian, Workday and More
Thursdays top analyst upgrades and downgrades included AbbVie, AutoZone, Boeing, Coupang, First Solar, Fortinet, Goldman Sachs, Johnson & Johnson, Marqeta,…
AbbVie: Kurzer Trade in Richtung Allzeithoch
AbbVie hat gerade am Aufwärtstrend gedreht und könnte kurz davor stehen, ein neues Kaufsignal auszulösen. Geht es jetzt wieder in…
AbbVie gets positive CHMP opinion for upadacitinib to treat Crohn’s disease in adults
Upadacitinib (RINVOQ, 45mg [induction dose] and 15mg and 30mg [maintenance doses]) is intended for those patients who have not shown…
This Pharmaceuticals Company Looks To Be A Better Pick Over Procter & Gamble Stock
There is more to the comparison, and in the sections below, we discuss the possible returns for P&G and AbbVie…
AbbVie, Capsida expand team up to develop genetic therapies for eye diseases
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
AbbVie and Capsida Biotherapeutics Expand Strategic Collaboration to Develop Targeted Genetic Medicines for Eye Diseases with High Unmet Need
Partnership Combines AbbVies extensive capabilities with Capsidas novel adeno-associated virus (AAV) engineering platform Builds upon the neurodegenerative disease partnership announced…
Übernahme von Botox-Hersteller gibt AbbVie Schub
Frankfurt (Reuters) - Der US-Pharmakonzern AbbVie profitiert von einer hohen Nachfrage nach seinem Blockbuster-Medikament Humira und der Übernahme des Botox-Herstellers…
Agentur - Boehringer und AbbVie in Gesprächen über Krebs-Allianz
Bangalore (Reuters) - Deutschlands zweitgrößter Pharmakonzern Boehringer Ingelheim steht einem Agenturbericht zufolge vor einer umfassenden Partnerschaft bei Krebs-Therapien mit dem…